ClassID:

21647

A61K2300/00 - page 47 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#13801
20090246124
2009-10-01

High affinity VEGF-receptor antagonists

#13802
20090239954
2009-09-24

PHOSPHATE BUFFERED OPHTHALMIC SOLUTIONS DISPLAYING IMPROVED EFFICACY

#13803
20090239947
2009-09-24

Inhibition of proliferation and fibrotic response of activated corneal stromal cells

#13804
20090239946
2009-09-24

Pharmaceutical compositions of HDAC inhibitors and chelatable metal compounds, and metal-HDAC inhibitors chelate complexes

#13805
20090239945
2009-09-24

Oral Composition with an Antiageing Effect on the Skin

#13806
20090239943
2009-09-24

Nutraceutical composition and methods for its use

#13807
20090239942
2009-09-24

Topiramate Compositions and Methods of Making and Using the Same

#13808
20090239927
2009-09-24

Statin and Omega-3 Fatty Acids For Lipid Therapy

#13809
20090239926
2009-09-24

METHODS FOR THE TREATMENT OF PSORIASIS OR PSORIATIC ARTHRITIS USING CYCLOPROPYL-N-CARBOXAMIDE

#13810
20090239914
2009-09-24

Phosphorus binder for treatment of renal disease

#13811
20090239900
2009-09-24

QUININE AND QUINIDINE SALTS, METHODS FOR MAKING THEM, AND PHARMACEUTICAL FORMULATIONS COMPRISING THEM

#13812
20090239881
2009-09-24

Combinations of Flibanserin with Caffeine, Process for Their Preparation and Use Thereof as Medicaments

#13813
20090239880
2009-09-24

COMBINATIONS OF MONOAMINE REUPTAKE INHIBITORS AND POTASSIUM CHANNEL ACTIVATORS

#13814
20090239878
2009-09-24

COMBINATIONS OF (A) AN ATP-COMPETITIVE INHIBITOR OF C-ABL KINASE ACTIVITY WITH (B) TWO OR MORE OTHER ANTINEOPLASTIC AGENTS

#13815
20090239850
2009-09-24

Kinase modulating compounds and uses thereof for treatment of cancer

#13816
20090239844
2009-09-24

ACE INHIBITOR-VASOPRESSIN ANTAGONIST COMBINATIONS

#13817
20090239835
2009-09-24

STABILIZATION OF GLUCOCORTICOID ESTERS WITH ACIDS

#13818
20090239833
2009-09-24

Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application

#13819
20090239831
2009-09-24

Compositions and methods for reducing hepatotoxicity associated with drug administration and treating non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and associated cirrhosis

#13820
20090239830
2009-09-24

Treatment of viral infections by modulation of host cell metabolic pathways

#13821
20090239826
2009-09-24

Compositions and methods for the regulation of homocysteine levels within the body

#13822
20090239825
2009-09-24

Multi-carotenoids compositions and uses therefor

#13823
20090239817
2009-09-24

ORGANIC THIOPHOSPHATE ANTIRETROVIRAL AGENTS

#13824
20090239783
2009-09-24

SYNERGISTIC EFFECTS OF COMBINED ADMINISTRATION OF MIRTAZAPINE AND A STIMULANT COMPOUND

#13825
20090239775
2009-09-24

OPHTHALMIC SOLUTIONS DISPLAYING IMPROVED EFFICACY

#13826
20090239236
2009-09-24

GENE DETECTION ASSAY FOR IMPROVING THE LIKELIHOOD OF AN EFFECTIVE RESPONSE TO AN EGFR ANTAGONIST CANCER THERAPY

#13827
20090238907
2009-09-24

Methods of inhibiting growth of bacteria, yeast, fungus, and virus with and extracellular products

#13828
20090238905
2009-09-24

INFLAMMATION REDUCING ACTION OF SYNERGISTIC MIXTURES OF BISABOLOL AND GINGER EXTRACTS

#13829
20090238902
2009-09-24

Chinese medicine composition and preparation method and use thereof

#13830
20090238898
2009-09-24

METHOD OF INHIBITING THE PROLIFERATION AND MIGRATION OF HELICOBACTOR PYLORI

#13831
20090238896
2009-09-24

Compositions and methods for diagnosing and treating melanoma

#13832
20090238895
2009-09-24

NUTRITIONAL AND/OR PHARMACEUTICAL PREPARATION FOR USE IN PROPHYLAXIS AND TREATMENT OF DISTURBANCES IN MICROELEMENTS ABSORPTION FROM THE ALIMENTARY CANAL

#13833
20090238879
2009-09-24

DELIVERY SCAFFOLDS AND RELATED METHODS OF USE

#13834
20090238872
2009-09-24

Chlorine dioxide releasing composite article

#13835
20090238852
2009-09-24

METHODS FOR CONTROLLING INTRACELLULAR CALCIUM LEVELS ASSOCIATED WITH AN ISCHEMIC EVENT

#13836
20090238820
2009-09-24

ANTI-MAdCAM ANTIBODY COMPOSITIONS

#13837
20090238818
2009-09-24

Induction of antigen specific immunnologic tolerance

#13838
20090238805
2009-09-24

Methods and compositions for increasing RNA interference

#13839
20090238796
2009-09-24

Preparation for treatment of non-infectious inflammatory intestinal diseases

#13840
20090238792
2009-09-24

SUPPRESSION OF POSTOPERATIVE ILEUS

#13841
20090238789
2009-09-24

Modified erythropoietin polypeptides and uses thereof for treatment

#13842
20090238773
2009-09-24

Use of Morpholino Compounds for the Treatment of Halitosis

#13843
20090238770
2009-09-24

Organic compounds

#13844
20090238764
2009-09-24

DIAGNOSTIC THERAPEUTIC METHOD

#13845
20090234019
2009-09-17

T type calcium channel inhibitors

#13846
20090234018
2009-09-17

Non-Standard Amino Acid Conjugates of Amphetamine and Processes for Making and Using the Same

#13847
20090234017
2009-09-17

TREATING SKIN DISORDERS

#13848
20090234013
2009-09-17

Pharmaceutical compositions having desirable bioavailability

#13849
20090234009
2009-09-17

Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof

#13850
20090234004
2009-09-17

PHARMACEUTICAL COMPOSITIONS HAVING DESIRABLE BIOAVAILABILITY

#13851
20090233996
2009-09-17

AVERMECTIN/BENZOYL PEROXIDE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA

#13852
20090233995
2009-09-17

Use of drug combinations for treating insulin resistance

#13853
20090233977
2009-09-17

Method of Treating Atherosclerosis, dyslipidemias and related conditions

#13854
20090233973
2009-09-17

EPOTHILONE DERIVATIVES FOR THE TREATMENT OF MULTIPLE MYELOMA

#13855
20090233970
2009-09-17

COMBINED NSAID AND ACID BLOCKER FORMULATION AND METHOD

#13856
20090233951
2009-09-17

Parenteral solutions containing metolazone

#13857
20090233939
2009-09-17

TREATMENT OF AMM

#13858
20090233914
2009-09-17

Composition for treatment of nail infections

#13859
20090233905
2009-09-17

COMBINATIONS COMPRISING BCR-ABL/C-KIT/PDGF-R TK INHIBITORS FOR TREATING CANCER

#13860
20090233898
2009-09-17

Pharmaceutical Compositions Comprising Simvastatin and Ezetimibe

#13861
20090233888
2009-09-17

TREATMENT OF DISEASE CONDITIONS THROUGH MODULATION OF HYDROGEN SULFIDE PRODUCED BY SMALL INTESTINAL BACTERIAL OVERGROWTH

#13862
20090233885
2009-09-17

Compositions and Methods for Fat Reduction

#13863
20090233882
2009-09-17

Methods and Compositions for the Treatment of Gastrointestinal Disorders

#13864
20090233877
2009-09-17

AVERMECTIN COMPOUNDS AND TREATMENT OF DERMATOLOGICAL DISORDERS THEREWITH

#13865
20090233865
2009-09-17

Nutritional compositions

#13866
20090233852
2009-09-17

Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof

#13867
20090232948
2009-09-17

ACTIVE PACKAGING THAT INHIBITS FOOD PATHOGENS

#13868
20090232934
2009-09-17

Nutritional weight loss agent and method

#13869
20090232917
2009-09-17

Composition for relieving subjective symptoms of fatigue

#13870
20090232914
2009-09-17

PHARMACEUTICAL COMPOSITION FOR TREATING DEPRESSION AND METHOD FOR PREPARATION THEREOF

#13871
20090232913
2009-09-17

Composition for the Control of Cholesterol Levels

#13872
20090232909
2009-09-17

Method for determining physiological effects of hemoglobin

#13873
20090232907
2009-09-17

Compositions and methods for treatment of esophageal cancer

#13874
20090232906
2009-09-17

Treatment methods and compositions for lung cancer, adenocarcinoma, and other medical conditions

#13875
20090232898
2009-09-17

Pharmaceutical Compositions Useful in the Treatment of Migraine

#13876
20090232884
2009-09-17

Composition and method for treatment of the side-effects associated with administration of cancer chemotherapeutic agents

#13877
20090232877
2009-09-17

In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide and platinum catalyst

#13878
20090232876
2009-09-17

In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide

#13879
20090232853
2009-09-17

TREATMENT OF LAMINITIS

#13880
20090232851
2009-09-17

Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative

#13881
20090232849
2009-09-17

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER

#13882
20090232835
2009-09-17

Composition for delivery of hematopoietic growth factor

#13883
20090232829
2009-09-17

Methods and compositions for treating inflammatory conditions

#13884
20090232828
2009-09-17

Methods of using IGFIR and ABL kinase modulators

#13885
20090232827
2009-09-17

Compositions and methods of use of compounds to increase cancer patient survival time

#13886
20090232805
2009-09-17

METHODS OF INHIBITING RECEPTOR TYROSINE KINASES WITH AN EXTRACELLULAR ANTAGONIST AND AN INTRACELLULAR ANTAGONIST

#13887
20090232800
2009-09-17

E1-MINUS ADENOVIRUSES AND USE THEREOF

#13888
20090232796
2009-09-17

METHOD OF TREATING CANCER BY ADMINISTERING AN IMMUNOMODULATORY COMPOUND IN COMBINATION WITH A CD40 ANTIBODY OR CD40 LIGAND

#13889
20090232792
2009-09-17

ANTIMICROBIAL CARBON

#13890
20090232791
2009-09-17

Methods and compositions for tissue regeneration

#13891
20090232790
2009-09-17

Kit of Lyophilized Thrombin and Lyophilized Fibrinogen Used to Compound Fibrin Membrane, and Its Application

#13892
20090232789
2009-09-17

Compositions and use thereof for treating symptoms of preeclampsia

#13893
20090232786
2009-09-17

HERBAL COMPOSITION FOR CANCER TREATMENT

#13894
20090232785
2009-09-17

Cosmetic and/or dermatological composition for prevention and/or treatment of sensitive or dry skin

#13895
20090232784
2009-09-17

ENDOTHELIAL PREDECESSOR CELL SEEDED WOUND HEALING SCAFFOLD

#13896
20090232769
2009-09-17

Pharmaceutical composition for treatment of blood clotting disorder

#13897
20090232767
2009-09-17

Methods for treating acute myeloid leukemia with diphtheria toxin-interleukin-3 conjugates

#13898
20090232749
2009-09-17

Compositions for the acute and/or long term treatment of periodontal diseases

#13899
20090232748
2009-09-17

Virucidal activities of cetylpyridinium chloride

#13900
20090227802
2009-09-10

BILAYER PHARMACEUTICAL TABLET COMPRISING TELMISARTAN AND A DIURETIC AND PREPARATION THEREOF

#13901
20090227683
2009-09-10

Compositions for Providing an Analgesic Effect to the Skin

#13902
20090227679
2009-09-10

Novel NIDDM Regimen

#13903
20090227676
2009-09-10

Methods and compositions for treating cancer

#13904
20090227674
2009-09-10

Combination methods fo saha and targretin for treating cancer

#13905
20090227673
2009-09-10

Method and Composition for the Treatment of Parkinson's Disease

#13906
20090227670
2009-09-10

Pharmaceutical compositions comprising flavonoids and menthol

#13907
20090227669
2009-09-10

Compositions and Methods for Perioperative Bladder Instillation

#13908
20090227665
2009-09-10

Methods for the treatment of kidney disease

#13909
20090227651
2009-09-10

PREVENTIVE AND/OR THERAPEUTIC AGENT FOR URINE COLLECTION DISORDER ACCOMPANYING LOWER URINARY TRACT OBSTRUCTION

#13910
20090227633
2009-09-10

Methods to inhibit tumor cell growth by using proton pump inhibitors

#13911
20090227632
2009-09-10

PHARMACEUTICAL COMPOSITION COMPRISING, IN COMBINATION, SAREDUTANT AND A SELECTIVE SEROTONIN REUPTAKE INHIBITOR OR A SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITOR

#13912
20090227562
2009-09-10

Combination of a Selective Noradrenaline Reuptake Unhibitor and a PDEV Inhibitor

#13913
20090227548
2009-09-10

Glucocorticoid receptor agonists

#13914
20090227546
2009-09-10

PHARMACEUTICAL COMPOSITION OF DROSPIRENONE AND ETHYNYLESTRADIOL

#13915
20090227534
2009-09-10

Pharmaceutical Composition Comprising the Combination of a Ketorolac Salt and Vitamins of the-B-Complex for the Treatment of Neuralgia

#13916
20090227529
2009-09-10

Combination treatment for bladder cancer

#13917
20090227523
2009-09-10

USE OF COMPATIBLE SOLUTES AS SUBSTANCES HAVING FREE RADICAL SCAVENGING PROPERTIES

#13918
20090227512
2009-09-10

METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING DISTAL BOWEL LESIONS

#13919
20090227511
2009-09-10

METHODS AND COMPOSITIONS FOR TREATING LESIONS OF THE RESPIRATORY EPITHELIUM

#13920
20090227495
2009-09-10

Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof

#13921
20090227494
2009-09-10

Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof

#13922
20090227493
2009-09-10

COMBINED DRUG FOR TREATING DIABETES

#13923
20090227492
2009-09-10

TREATMENT OF NEUROLOGICAL CONDITIONS USING COMPLEMENT C5a RECEPTOR MODULATORS

#13924
20090227490
2009-09-10

Antitumoral Treatments

#13925
20090227022
2009-09-10

Methods of stimulating bone growth using ZVEGF4 polypeptides

#13926
20090227000
2009-09-10

Chimeric adenoviruses for use in cancer treatment

#13927
20090226551
2009-09-10

Pharmaceutical composition for prevention and/or treatment of bone loss

#13928
20090226550
2009-09-10

ORGANIC COMPOSITIONS AND METHODS OF USE

#13929
20090226548
2009-09-10

METHOD OF PREVENTING, CONTROLLING AND AMELIORATING URINARY TRACT INFECTIONS USING A SYNERGISTIC CRANBERRY DERIVATIVE AND D-MANNOSE COMPOSITION

#13930
20090226545
2009-09-10

Anti-glycation methods and compositions

#13931
20090226544
2009-09-10

Pharmaceutical Compound For Treating Inflammation, Pain, Arthritis And Spinitis, And Proliferating Osteoblastic Cell And Method For Producing Thereof

#13932
20090226543
2009-09-10

AGENT FOR THE THERAPY AND PROPHYLAXIS OF DIABETES MELLITUS

#13933
20090226540
2009-09-10

Methods and compositions for treating feline hyperthyroidism

#13934
20090226539
2009-09-10

Treatment of ovarian cancer

#13935
20090226538
2009-09-10

ANTICANCER OR ANTIVIRAL COMPOSITION

#13936
20090226536
2009-09-10

METHODS AND MATERIALS RELATING TO ENHANCED PRODUCTION OF DOPAMINE NEURONS

#13937
20090226527
2009-09-10

Particulate-stabilized injectable pharmacutical compositions of posaconazole

#13938
20090226526
2009-09-10

NANOPARTICLES OF A HETEROCRYSTAL MINERAL FOR USE AS A MEDICAMENT AND METHOD OF PRODUCING THE SAME

#13939
20090226518
2009-09-10

(MONITORING ONLY) COMBINATIONS OF HMG-COA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPELIPIDEMIA ONCE A DAY AT NIGHT

#13940
20090226510
2009-09-10

PHARMACEUTICAL COMPOSITIONS OF ATORVASTATIN

#13941
20090226508
2009-09-10

Methods And Materials For Immunization Against Cancer

#13942
20090226507
2009-09-10

HYDROXIDE-RELEASING AGENTS AS SKIN PERMEATION ENHANCERS

#13943
20090226494
2009-09-10

PATHOGEN - CONTROLLING PRODUCTS

#13944
20090226483
2009-09-10

SUPER BROWN CREAM

#13945
20090226482
2009-09-10

Herbal composition for treatment of insomnia and other related disorders and a method of preparing the same

#13946
20090226468
2009-09-10

Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the CNS

#13947
20090226453
2009-09-10

Sphingosine 1-phosphate antagonism

#13948
20090226443
2009-09-10

COMBINATION THERAPY WITH C-MET AND EGFR ANTAGONISTS

#13949
20090226441
2009-09-10

ACTIVIN RECEPTOR-LIKE KINASE-1 COMPOSITIONS AND METHODS OF USE

#13950
20090226439
2009-09-10

METHOD FOR TREATING DEMENTIA OR ALZHEIMER'S DISEASE

#13951
20090226429
2009-09-10

Antibodies That Immunospecifically Bind to TRAIL Receptors

#13952
20090226426
2009-09-10

Method for treating inflammation

#13953
20090226424
2009-09-10

Subdermal tissue remodeling using myostatin, methods and related systems

#13954
20090226422
2009-09-10

Chemical inhibitors of inhibitors of differentiation

#13955
20090226418
2009-09-10

Food Products Comprising Probiotic Micro-Organisms and Antibodies

#13956
20090226414
2009-09-10

Method for detecting infectious parvovirus in pharmaceutical preparations

#13957
20090226409
2009-09-10

Pharmaceutical compositions comprising SODs and prolamine based peptide fragments

#13958
20090226408
2009-09-10

ANTI-FATIGUE COMPOSITION

#13959
20090226407
2009-09-10

Methods of treating vascular diseases characterized by nitric oxide insufficiency

#13960
20090226399
2009-09-10

MEDICAMENTS COMPRISING GENE RECOMBINANT ANTIBODY AGAINST GANGLIOSIDE GD3

#13961
20090226397
2009-09-10

COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF IMPLANTATION FAILURE OR MISCARRIAGE IN RECIPIENTS OF ARTIFICIAL INSEMINATION

#13962
20090226384
2009-09-10

ANTIMICROBIAL COMPOSITION CONTAINING TRICLOSAN AND AT LEAST ONE FUNCTIONALIZED HYDROCARBON

#13963
20090226370
2009-09-10

Methods for using GEP, a chondrogenic growth factor and target in cartilage disorders

#13964
20090226367
2009-09-10

COMPOSITIONS COMPRISING AN ANTI-CA125 ANTIBODY AND A CYTOTOXIC COMPOUND AND THEIR USE FOR THE TREATMENT OF CANCER

#13965
20090221989
2009-09-03

SYSTEM AND METHOD FOR THE PREVENTION AND TREATMENT OF BACTERIAL AND FUNGAL INFECTIONS INCLUDING URINARY TRACT INFECTIONS (UTI) USING A HYPOHALOUS ACID COMPOSITION

#13966
20090221698
2009-09-03

Mannose derivatives for killing tumor cells

#13967
20090221694
2009-09-03

Nutraceutical compositions comprising epigallocatechin gallate and raspberry ketone

#13968
20090221692
2009-09-03

CB2 receptors blocks accumulation of human hepatic myofibroblasts: a novel antifibrogenic pathway in the liver

#13969
20090221683
2009-09-03

Combination of CXCR4 Antagonist and Morphogen to Increase Angiogenesis

#13970
20090221665
2009-09-03

Organic Compounds

#13971
20090221659
2009-09-03

Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea

#13972
20090221658
2009-09-03

Pharmacological Treatment for Sleep Apnea

#13973
20090221652
2009-09-03

COMBINATIONS OF METFORMIN AND MEGLITINIDE

#13974
20090221648
2009-09-03

COMPOSITIONS FOR TREATMENT OF COGNITIVE DISORDERS

#13975
20090221628
2009-09-03

Compositions and methods for treatment of prostate and breast cancer

#13976
20090221615
2009-09-03

COMBINATION ANTI-CANCER AGENTS

#13977
20090221610
2009-09-03

Compositions and Methods for Treating Cognitive Disorders

#13978
20090221570
2009-09-03

Uses of 2-Phenyl-Substituted Imidazotriazinone Derivatives for Treating Pulmonary Hypertension

#13979
20090221554
2009-09-03

METHOD OF TREATING COGNITIVE IMPAIRMENT

#13980
20090221550
2009-09-03

Compositions for treatment of systemic mastocytosis

#13981
20090221538
2009-09-03

METHODS OF TREATING MULTIPLE SCLEROSIS BY ADMINISTERING PULSE DOSE CALCITRIOL

#13982
20090221528
2009-09-03

Therapeutic micro nutrient composition for lipolysis and sclerosis

#13983
20090221526
2009-09-03

NGNA compositions and methods of use

#13984
20090221521
2009-09-03

Systemic purine administration: modulating axonal outgrowth of central nervous system neurons

#13985
20090221519
2009-09-03

COMBINATIONS OF RECEPTOR TYROSINE KINASE INHIBITOR WITH AN A1-ACIDIC GLYCOPROTEIN BINDING COMPOUND

#13986
20090221502
2009-09-03

Vegetarian anabolic protein composition

#13987
20090221497
2009-09-03

Immunodynamic complexes and methods for using and preparing such complexes

#13988
20090221488
2009-09-03

Certain Compositions and Methods of Treatment

#13989
20090221486
2009-09-03

METHOD FOR TREATING AND/OR PREVENTING INFECTIONS IN INFANTS DELIVERED VIA CAESAREAN SECTION

#13990
20090221480
2009-09-03

Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof

#13991
20090221472
2009-09-03

Method for treating transplant rejection

#13992
20090221470
2009-09-03

Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent

#13993
20090221469
2009-09-03

USE OF SOY KEFIR POWDER FOR REDUCING PAIN, BLOOD PRESSURE AND INFLAMMATION

#13994
20090220639
2009-09-03

Preventing diseases in infants delivered via caesarean section

#13995
20090220627
2009-09-03

NOVEL VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION INHIBITORS

#13996
20090220626
2009-09-03

GRAPE SEED EXTRACT AND ITS CONSTITUENTS FOR USE AS CYP2A6 INHIBITORS

#13997
20090220624
2009-09-03

Compositions comprising apocynin, ginkgo and ginger and uses thereof

#13998
20090220623
2009-09-03

Herbal acne control composition, method of manufacturing the same and use thereof

#13999
20090220617
2009-09-03

Method of treating parturient placental mammals in order to reduce maternal and/or uterine exhaustion

#14000
20090220598
2009-09-03

Stable Oral Pharmaceutical Composition Containing Thyroid Hormone Receptor Agonists

#14001
20090220595
2009-09-03

Combination of erythropoietin glycoisoforms

#14002
20090220592
2009-09-03

PREPARATION FOR THE TREATMENT OF TINNITUS

#14003
20090220591
2009-09-03

Pharmaceutical compositions comprising non-steroidal antiinflammatory drug, antipyretic-analgesic drug and proton pump inhibitor

#14004
20090220590
2009-09-03

Triple drug combinations for psychiatric patients

#14005
20090220588
2009-09-03

Simultaneous Delivery of Receptors and/or Co-Receptors for Growth Factor Stability and Activity

#14006
20090220574
2009-09-03

Suramin and derivatives thereof as topical microbicide and contraceptive

#14007
20090220562
2009-09-03

Osteogenic and anti-adipogenic oxysterols

#14008
20090220518
2009-09-03

METHODS AND COMPOSITIONS FOR TREATMENT OF GRAFT REJECTION AND PROMOTION OF GRAFT SURVIVAL

#14009
20090220516
2009-09-03

Neuroprotection of retinal ganglion cells

#14010
20090220510
2009-09-03

Specific binding proteins and uses thereof

#14011
20090220507
2009-09-03

INHIBITION OF EXTRACELLULAR SIGNAL-REGULATED KINASE 1/2 AS A TREATMENT FOR CARDIAC HYPERTROPHY AND HEART FAILURE

#14012
20090220497
2009-09-03

Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment

#14013
20090220481
2009-09-03

Method and compositions for treating skin

#14014
20090220478
2009-09-03

Pharmaceutical active substance

#14015
20090220477
2009-09-03

Prevention of micronutrient deficiencies associated with common disabilities in the over 50 adult

#14016
20090220468
2009-09-03

Specific CD4+CD25+ Regulatory T Cells for Haematopoietic Cell Transplantation and Immune Tolerance

#14017
20090220457
2009-09-03

COMBINATIONS COMPRISING HCV PROTEASE INHIBITOR(S) AND HCV IRES INHIBITOR(S), AND METHODS OF TREATMENT RELATED THERETO

#14018
20090220454
2009-09-03

Hydroxamates as therapeutic agents

#14019
20090220453
2009-09-03

Enhancing stem cell mobilization

#14020
20090220450
2009-09-03

Methods and compositions for wound healing

#14021
20090220440
2009-09-03

Spray Composition for Topical Use for Treating and/or Preventing Herpes Simplex Labial Infections

#14022
20090220435
2009-09-03

TIGHT JUNCTION MODULATING PEPTIDE COMPONENTS FOR ENHANCING MUCOSAL DELIVERY OF THERAPEUTIC AGENTS

#14023
20090216318
2009-08-27

Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy

#14024
20090215886
2009-08-27

Anti-inflammatory formulation

#14025
20090215885
2009-08-27

Antioxidant Food Composition and Methods and Uses Thereof

#14026
20090215854
2009-08-27

Antimicrobial compositions, products and methods employing same

#14027
20090215853
2009-08-27

Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer

#14028
20090215852
2009-08-27

COMPOSITIONS AND METHODS FOR AMELIORATING CACHEXIA

#14029
20090215834
2009-08-27

6-oxo-1,6-dihydropyridine derivatives as inhibitors of MEK and methods of use thereof

#14030
20090215823
2009-08-27

Compositions and methods for effecting NADlevels using a nicotinamide phosphoribosyl transferase inhibitor

#14031
20090215811
2009-08-27

Pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion

#14032
20090215793
2009-08-27

Methods for treating drug resistant cancer

#14033
20090215792
2009-08-27

Method of treating chronic myelogenous leukemia cells

#14034
20090215755
2009-08-27

USE OF A PYRAZOLE DERIVATIVE FOR PREPARING MEDICINAL PRODUCTS THAT ARE USEFUL IN THE PREVENTION AND TREATMENT OF DYSLIPIDAEMIAS AND OF DISEASES RELATED TO DYSLIPIDAEMIAS AND/OR TO OBESITY

#14035
20090215751
2009-08-27

Use of Selective Chloride Channel Modulators to Treat Alcohol and/or Stimulant Substance Abuse

#14036
20090215747
2009-08-27

HETEROCYCLIC COMPOUNDS AS INHIBITORS OF BETA-LACTAMASES

#14037
20090215745
2009-08-27

Association of a sinus node If current inhibitor and a calcium inhibitor, and pharmaceutical compositions containing it

#14038
20090215738
2009-08-27

PREVENTION AND TREATMENT OF AN INCREASE IN CARDIOVASCULAR RISK, ADVERSE CARDIOVASCULAR EVENTS, INFERTILITY, AND ADVERSE PSYCHOLOGICAL EFFECTS AFTER ANDROGEN OR GNRH ANALOGUE INTAKE

#14039
20090215737
2009-08-27

Pharmaceutical Compositions - 2

#14040
20090215734
2009-08-27

METHOD AND SYSTEM FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH NEBULIZED ANTICHOLINERGIC ADMINISTRATIONS

#14041
20090215733
2009-08-27

THERAPY FOR THE PROPHYLAXIS OR TREATMENT OF ADVERSE BODY COMPOSITION CHANGES AND/OR DECREASED MUSCLE STRENGTH AFTER ANDROGEN OR GNRH ANALOGUE INTAKE

#14042
20090215732
2009-08-27

COMBINATION OF COMPOUNDS, WHICH CAN BE USED IN THE TREATMENT OF RESPIRATORY DISEASES, ESPECIALLY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND ASTHMA

#14043
20090215731
2009-08-27

Reduction of Side Effects From Aromatase Inhibitors Used for Treating Breast Cancer

#14044
20090215720
2009-08-27

Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation

#14045
20090215718
2009-08-27

Carbohydrate composition for flat glucose response

#14046
20090215714
2009-08-27

Pyrimidines, such as cytidine, in treatments for patients with biopolar disorder

#14047
20090215701
2009-08-27

Enhancement of iron chelation therapy

#14048
20090215674
2009-08-27

USE OF A POLYENE MACROLIDE ANTIFUNGAL AGENT IN COMBINATION WITH A GLYCOPEPTIDE ANTIBACTERIAL AGENT

#14049
20090215669
2009-08-27

COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETES

#14050
20090215164
2009-08-27

Recombinant gene of adenovirus vector and p53 gene for treating proliferative diseases

#14051
20090215147
2009-08-27

Use of mutant Herpes Simplex Virus-2 for cancer therapy

#14052
20090214682
2009-08-27

Composition and methods for weight loss in a subject

#14053
20090214680
2009-08-27

Weight loss composition

#14054
20090214678
2009-08-27

Herbal Formulation for the Prevention and Management of Diabetes Mellitus and Diabetic Micro-Vascular Complications

#14055
20090214676
2009-08-27

METHOD FOR TREATING OCULAR DEMODEX

#14056
20090214669
2009-08-27

Combination anticancer therapy and pharmaceutical compositions therefore

#14057
20090214664
2009-08-27

Pharmaceutical dosage forms comprising an active ingredient combination of nifedipine and/or nisoldipine and an angiotensin II antagonist

#14058
20090214658
2009-08-27

Inorganic sorbent copolymer

#14059
20090214650
2009-08-27

Methods of Treating alcoholism and alcohol related disorders using combination drug therapy and swellable polymers

#14060
20090214620
2009-08-27

AGENT FOR USE IN THE CASE OF DISORDERS OF BLOOD SUGAR METABOLISM, INCLUDING DIABETES

#14061
20090214614
2009-08-27

Method for Cell Implantation

#14062
20090214602
2009-08-27

Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor

#14063
20090214580
2009-08-27

Peptide mixtures with immunomodulatory activity

#14064
20090214562
2009-08-27

Combination of a beta-glucan and an egf receptor antagonist for the treatment of cancer and infection

#14065
20090214544
2009-08-27

Method of treating cd30 positive lymphomas

#14066
20090214539
2009-08-27

B-CELL REDUCTION USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES

#14067
20090214538
2009-08-27

Use of complement inhibitors to treat ocular diseases

#14068
20090214529
2009-08-27

KINESIN INHIBITORS

#14069
20090214527
2009-08-27

Combination Of Anti-Madcam Antibody And Antifibrotic Caspase Inhibitor To Treat Liver Fibrosis

#14070
20090214511
2009-08-27

DIGESTIBLE COMPOSITIONS OF INULIN FOR MANAGING BLOOD GLUCOSE LEVELS

#14071
20090214507
2009-08-27

METHOD OF TREATING PREVENTING, INHIBITING OR REDUCING DAMAGE TO CARDIAC TISSUE

#14072
20090214504
2009-08-27

Methods and compositions for topical treatment of medical conditions including wounds and inflammation

#14073
20090214501
2009-08-27

GEL-BASED COSMETIC AND WOUND-HEALING FORMULATION AND METHOD

#14074
20090214495
2009-08-27

VASCULAR ENDOTHELIAL GROWTH FACTOR-D (VEGF)-D AND FUNCTIONALLY FRAGMENTS THEREOF FOR BONE REPAIRING

#14075
20090214494
2009-08-27

Cancer Vaccines and Therapeutic Methods

#14076
20090214492
2009-08-27

ISOLATED STROMAL CELLS FOR USE IN THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM

#14077
20090214474
2009-08-27

Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development

#14078
20090214473
2009-08-27

COMBINATION CHAPERONIN 10 AND BETA-INTERFERON THERAPY FOR MULTIPLE SCLEROSIS

#14079
20090214470
2009-08-27

Eye-drop vaccine containing copolymer 1 for therapeutic immunization

#14080
20090214469
2009-08-27

Methods and Compositions for the Treatment of Sepsis

#14081
20090214468
2009-08-27

Localized insulin delivery for bone healing

#14082
20090214466
2009-08-27

Methods of Alleviating Disorders and Their Associated Pain

#14083
20090214464
2009-08-27

COMPOUNDS FOR FLAVIVIRIDAE TREATMENT

#14084
20090214438
2009-08-27

METHODS AND COMPOSITIONS FOR THE PREPARATION AND USE OF TOXIN CONJUGATES

#14085
20090214435
2009-08-27

Recombinant vector expressing MDR1 shRNA and thymidine kinase and use thereof

#14086
20090214434
2009-08-27

METHOD OF DETECTING AND TREATING ALLOGENIC CELLS RESPONSIBLE FOR ENDOMETRIOSIS

#14087
20090214425
2009-08-27

Tumor therapy with replication competent sindbis viral vectors

#14088
20090213731
2009-08-27

USE OF NEUROPEPTIDE Y (NPY) AND AGONISTS AND ANTAGONISTS THEREOF FOR TISSUE REGENERATION

#14089
20090211493
2009-08-27

Different Types Of Mineral Matter Containing Carbonate With Reduced Fossil Fuel Carbon Dioxide Emission On Breakdown, Together With Their Synthesis Process And Their Uses

#14090
20090209902
2009-08-20

KIT FOR ADMINSTERING A THERAPEUTIC AGENT INTO TISSUE

#14091
20090209901
2009-08-20

Apparatus for administering a therapeutic agent into tissue

#14092
20090209644
2009-08-20

Lipotoxicity relieving agent

#14093
20090209640
2009-08-20

Prevention of and countermeasures against viral infection

#14094
20090209613
2009-08-20

Use of allymercaptocaptopril for treating or preventing obesity and obesity related diseases

#14095
20090209604
2009-08-20

Topical combination therapy for treating acne

#14096
20090209574
2009-08-20

FLUOROQUINOLONE DERIVATIVES FOR OPHTHALMIC APPLICATIONS

#14097
20090209562
2009-08-20

Fused ring 4-oxopyrimidine derivative

#14098
20090209542
2009-08-20

Heterocyclic inhibitors of MEK and methods of use thereof

#14099
20090209535
2009-08-20

6-ETHER/THIOETHER-PURINES AS TOPOISOMERASE II CATALYTIC INHIBITORS AND THEIR USE IN THERAPY

#14100
20090209515
2009-08-20

Association of a sinus node if current inhibitor and a beta blocker